Intervention Review

You have free access to this content

Omega-3 fatty acids for cystic fibrosis

  1. Colleen Oliver1,*,
  2. Helen Watson2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 27 NOV 2013

Assessed as up-to-date: 26 NOV 2013

DOI: 10.1002/14651858.CD002201.pub4


How to Cite

Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD002201. DOI: 10.1002/14651858.CD002201.pub4.

Author Information

  1. 1

    The Royal Women's Hospital, Parkville, VIC, Australia

  2. 2

    Papworth Hospital NHS Foundation Trust, Cambridge Centre for Lung Infection, Cambridge, UK

*Colleen Oliver, The Royal Women's Hospital, Grattan St & Flemington Rd, Parkville, VIC, 3052, Australia. cmckarney@yahoo.com.au. colleen.oliver@thewomens.org.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 27 NOV 2013

SEARCH

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 1 Adverse events.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 2 Lung function.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 3 Clinical variables.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 4 Biochemical markers of essential fatty acid status (EPA & DHA content).
[Analysis 1.5]
Analysis 1.5. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 5 Biochemical markers of essential fatty acid status (B4/B5 ratio).
[Analysis 1.6]
Analysis 1.6. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 6 Biochemical markers of essential fatty acid status (EPA & DHA content).
[Analysis 1.7]
Analysis 1.7. Comparison 1 Omega-3 fatty acids versus placebo, Outcome 7 Biochemical markers of essential fatty acid status (n6/n3).